Construction of a Saccharomyces cerevisiae strain expressing the Leishmania major nucleoside hydrolase gene

about

Construction of a Saccharomyces cerevisiae strain expressing the Leishmania major nucleoside hydrolase gene

Item

http://www.wikidata.org/entity/Q35741614

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@ast

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@en

type

Item

label

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@ast

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@en

prefLabel

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@ast

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@en

P1476

Construction of a Saccharomyce ...... ajor nucleoside hydrolase gene

@en

P2093

Champa Patel

http://www.w3.org/2001/XMLSchema#string

Claude P Selitrennikoff

http://www.w3.org/2001/XMLSchema#string

Tamara K Miller

http://www.w3.org/2001/XMLSchema#string

P2860

The genome of the kinetoplastid parasite, Leishmania major

Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-å crystal structure

Saccharomyces cerevisiae URH1 (encoding uridine-cytidine N-ribohydrolase): functional complementation by a nucleoside hydrolase from a protozoan parasite and by a mammalian uridine phosphorylase.

Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure

A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite.

Toxicity of antimony and its compounds.

Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.

Purine and pyrimidine salvage pathways in Leishmania donovani.

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

P304

103-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJANTIMICAG.2006.08.029

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6658477

http://www.w3.org/2001/XMLSchema#string

P698

17141482

http://www.w3.org/2001/XMLSchema#string

P932

1847609

http://www.w3.org/2001/XMLSchema#string